BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16996506)

  • 21. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin.
    Yang Q; McHugh KP; Patntirapong S; Gu X; Wunderlich L; Hauschka PV
    Matrix Biol; 2008 Sep; 27(7):589-99. PubMed ID: 18640270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell.
    Bar-Shavit Z
    J Cell Biochem; 2007 Dec; 102(5):1130-9. PubMed ID: 17955494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical force inhibits osteoclastogenic potential of human periodontal ligament fibroblasts through OPG production and ERK-mediated signaling.
    Kook SH; Son YO; Hwang JM; Kim EM; Lee CB; Jeon YM; Kim JG; Lee JC
    J Cell Biochem; 2009 Apr; 106(6):1010-9. PubMed ID: 19206164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
    Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Mac-1 (CD11b/CD18) in osteoclast differentiation induced by receptor activator of nuclear factor-kappaB ligand.
    Hayashi H; Nakahama K; Sato T; Tuchiya T; Asakawa Y; Maemura T; Tanaka M; Morita M; Morita I
    FEBS Lett; 2008 Sep; 582(21-22):3243-8. PubMed ID: 18775427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brn3 transcription factors control terminal osteoclastogenesis.
    Schulze-Späte U; Battaglino R; Fu J; Sharma A; Vokes M; Stashenko P
    J Cell Biochem; 2007 Sep; 102(1):1-12. PubMed ID: 17668438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases.
    Agidigbi TS; Kim C
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures.
    Nicolin V; Bareggi R; Baldini G; Bortul R; Martinelli B; Narducci P
    Acta Histochem; 2007; 109(5):397-402. PubMed ID: 17574655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration.
    Brazier H; Pawlak G; Vives V; Blangy A
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1391-401. PubMed ID: 19135548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF.
    Stemig M; Astelford K; Emery A; Cho JJ; Allen B; Huang TH; Gopalakrishnan R; Mansky KC; Jensen ED
    PLoS One; 2015; 10(4):e0123843. PubMed ID: 25875108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide.
    Liu F; Zhu Z; Mao Y; Liu M; Tang T; Qiu S
    Biomaterials; 2009 Mar; 30(9):1756-62. PubMed ID: 19118894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation.
    Lean JM; Jagger CJ; Kirstein B; Fuller K; Chambers TJ
    Endocrinology; 2005 Feb; 146(2):728-35. PubMed ID: 15528306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From macrophage to osteoclast - How metabolism determines function and activity.
    Kubatzky KF; Uhle F; Eigenbrod T
    Cytokine; 2018 Dec; 112():102-115. PubMed ID: 29914791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive profiling analysis of actively resorbing osteoclasts identifies critical signaling pathways regulated by bone substrate.
    Purdue PE; Crotti TN; Shen Z; Swantek J; Li J; Hill J; Hanidu A; Dimock J; Nabozny G; Goldring SR; McHugh KP
    Sci Rep; 2014 Dec; 4():7595. PubMed ID: 25534583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental model for studying the involvement of regulatory cytotoxic T cells in bone resorption.
    Brunetti G; Oranger A; Colucci S; Grano M
    Methods Mol Biol; 2014; 1186():269-81. PubMed ID: 25149313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoclast radicals.
    Silverton S
    J Cell Biochem; 1994 Nov; 56(3):367-73. PubMed ID: 7876330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steap4 plays a critical role in osteoclastogenesis in vitro by regulating cellular iron/reactive oxygen species (ROS) levels and cAMP response element-binding protein (CREB) activation.
    Zhou J; Ye S; Fujiwara T; Manolagas SC; Zhao H
    J Biol Chem; 2013 Oct; 288(42):30064-30074. PubMed ID: 23990467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoclasts pump iron.
    Roodman GD
    Cell Metab; 2009 May; 9(5):405-6. PubMed ID: 19416710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A crucial role for thiol antioxidants in estrogen-deficiency bone loss.
    Lean JM; Davies JT; Fuller K; Jagger CJ; Kirstein B; Partington GA; Urry ZL; Chambers TJ
    J Clin Invest; 2003 Sep; 112(6):915-23. PubMed ID: 12975476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local factors affecting bone resorption and estrogens.
    Cohen-Solal ME; de Vernejoul MC
    Rev Rhum Engl Ed; 1999 Nov; 66(11):525-6. PubMed ID: 10591110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.